For the quarter ending 2026-03-31, LPCN had -$190,234 decrease in cash & cash equivalents over the period.
| Cash Flow | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 |
|---|---|---|---|---|
| Non-cash loss on change in fair value of warrant liability | - | - | - | 0 |
| Net loss attributable to common shareholders | -3,671,894 | -2,370,084 | -3,186,832 | -4,070,589 |
| Depreciation expense | 14,814 | 14,981 | 14,123 | 31,678 |
| Stock-based compensation expense | 65,398 | 53,034 | 53,256 | 136,207 |
| Amortization of discounts on marketable investment securities | 96,418 | 66,405 | 33,908 | 92,625 |
| Accrued interest income | 97,222 | -101,083 | -6,460 | 1,285 |
| License and royalties receivable | -1,025,993 | 1,053,985 | - | - |
| Prepaid and other current assets | -502,545 | 195,208 | 321,168 | -205,286 |
| Accounts payable | 590,906 | 110,370 | 418,458 | 171,298 |
| Accrued expenses | -591,259 | 486,707 | 63,888 | -235,461 |
| Cash used in operating activities | -2,257,137 | -2,919,507 | -2,985,723 | -3,855,491 |
| Purchases of marketable investment securities | 15,204,139 | 4,428,291 | 5,198,551 | 5,082,073 |
| Maturities of marketable investment securities | 5,300,000 | 6,000,000 | 5,900,000 | 8,700,000 |
| Net cash used in investing activities | -9,904,139 | 1,571,709 | 701,449 | 3,617,927 |
| Net proceeds from sale of common stock through atm | 11,964,056 | 2,652,600 | 141,334 | 75,618 |
| Proceeds from stock option exercises | 6,986 | - | - | - |
| Cash provided by financing activities | 11,971,042 | 2,652,600 | 141,334 | 75,618 |
| Net decrease in cash and cash equivalents | -190,234 | 1,304,802 | -2,142,940 | -161,946 |
| Cash and cash equivalents at beginning of period | 5,205,842 | 3,901,040 | 6,205,926 | - |
| Cash and cash equivalents at end of period | 5,015,608 | 5,205,842 | 3,901,040 | - |